91 related articles for article (PubMed ID: 27481029)
1. Notification: Construction and Consensus Performance of (Q)SAR Models for Predicting Phospholipidosis Using a Dataset of 743 Compounds.
Orogo AM; Choi SS; Minnier BL; Kruhlak NL
Mol Inform; 2013 Jan; 32(1):121. PubMed ID: 27481029
[No Abstract] [Full Text] [Related]
2. Construction and Consensus Performance of (Q)SAR Models for Predicting Phospholipidosis Using a Dataset of 743 Compounds.
Orogo AM; Choi SS; Minnier BL; Kruhlak NL
Mol Inform; 2012 Oct; 31(10):725-39. PubMed ID: 27476455
[TBL] [Abstract][Full Text] [Related]
3. In silico modeling to predict drug-induced phospholipidosis.
Choi SS; Kim JS; Valerio LG; Sadrieh N
Toxicol Appl Pharmacol; 2013 Jun; 269(2):195-204. PubMed ID: 23541745
[TBL] [Abstract][Full Text] [Related]
4. Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Kruhlak NL; Choi SS; Contrera JF; Weaver JL; Willard JM; Hastings KL; Sancilio LF
Toxicol Mech Methods; 2008; 18(2-3):217-27. PubMed ID: 20020916
[TBL] [Abstract][Full Text] [Related]
5. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
[TBL] [Abstract][Full Text] [Related]
6. Combinatorial QSAR modeling of chemical toxicants tested against Tetrahymena pyriformis.
Zhu H; Tropsha A; Fourches D; Varnek A; Papa E; Gramatica P; Oberg T; Dao P; Cherkasov A; Tetko IV
J Chem Inf Model; 2008 Apr; 48(4):766-84. PubMed ID: 18311912
[TBL] [Abstract][Full Text] [Related]
7. (Q)SAR: A Tool for the Toxicologist.
Steinbach T; Gad-McDonald S; Kruhlak N; Powley M; Greene N
Int J Toxicol; 2015; 34(4):352-4. PubMed ID: 25979517
[TBL] [Abstract][Full Text] [Related]
8. Testing computational toxicology models with phytochemicals.
Valerio LG; Arvidson KB; Busta E; Minnier BL; Kruhlak NL; Benz RD
Mol Nutr Food Res; 2010 Feb; 54(2):186-94. PubMed ID: 20024931
[TBL] [Abstract][Full Text] [Related]
9. SAR modeling of genotoxic phenomena: the consequence on predictive performance of deviation from a unity ratio of genotoxicants/non-genotoxicants.
Rosenkranz HS
Mutat Res; 2004 Apr; 559(1-2):67-71. PubMed ID: 15066575
[TBL] [Abstract][Full Text] [Related]
10. Screening for phospholipidosis induced by central nervous drugs: comparing the predictivity of an in vitro assay to high throughput in silico assays.
Mesens N; Steemans M; Hansen E; Verheyen GR; Van Goethem F; Van Gompel J
Toxicol In Vitro; 2010 Aug; 24(5):1417-25. PubMed ID: 20430096
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the OECD (Q)SAR Application Toolbox and Toxtree for predicting and profiling the carcinogenic potential of chemicals.
Mombelli E; Devillers J
SAR QSAR Environ Res; 2010 Oct; 21(7-8):731-52. PubMed ID: 21120759
[TBL] [Abstract][Full Text] [Related]
12. Consensus hologram QSAR modeling for the prediction of human intestinal absorption.
Moda TL; Andricopulo AD
Bioorg Med Chem Lett; 2012 Apr; 22(8):2889-93. PubMed ID: 22425566
[TBL] [Abstract][Full Text] [Related]
13. Predicting in vivo phospholipidosis-inducing potential of drugs by a combined high content screening and in silico modelling approach.
Bauch C; Bevan S; Woodhouse H; Dilworth C; Walker P
Toxicol In Vitro; 2015 Apr; 29(3):621-30. PubMed ID: 25668432
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential.
Pelletier DJ; Gehlhaar D; Tilloy-Ellul A; Johnson TO; Greene N
J Chem Inf Model; 2007; 47(3):1196-205. PubMed ID: 17428028
[TBL] [Abstract][Full Text] [Related]
15. The role of the European Chemicals Bureau in promoting the regulatory use of (Q)SAR methods.
Worth AP; Bassan A; De Bruijn J; Gallegos Saliner A; Netzeva T; Patlewicz G; Pavan M; Tsakovska I; Eisenreich S
SAR QSAR Environ Res; 2007; 18(1-2):111-25. PubMed ID: 17365963
[TBL] [Abstract][Full Text] [Related]
16. In Silico Studies of the Relationship Between Chemical Structure and Drug Induced Phospholipidosis.
Przybylak KR; Cronin MT
Mol Inform; 2011 May; 30(5):415-29. PubMed ID: 27467088
[TBL] [Abstract][Full Text] [Related]
17. Nano(Q)SAR: Challenges, pitfalls and perspectives.
Tantra R; Oksel C; Puzyn T; Wang J; Robinson KN; Wang XZ; Ma CY; Wilkins T
Nanotoxicology; 2015; 9(5):636-42. PubMed ID: 25211549
[TBL] [Abstract][Full Text] [Related]
18. In vitro assays and biomarkers for drug-induced phospholipidosis.
Monteith DK; Morgan RE; Halstead B
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):687-96. PubMed ID: 17014389
[TBL] [Abstract][Full Text] [Related]
19. Performance of (consensus) kNN QSAR for predicting estrogenic activity in a large diverse set of organic compounds.
Asikainen AH; Ruuskanen J; Tuppurainen KA
SAR QSAR Environ Res; 2004 Feb; 15(1):19-32. PubMed ID: 15113066
[TBL] [Abstract][Full Text] [Related]
20. Current situation on the availability of nanostructure-biological activity data.
Oksel C; Ma CY; Wang XZ
SAR QSAR Environ Res; 2015; 26(2):79-94. PubMed ID: 25608859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
